Each weekend I highlight any notable articles that I came across over the past week. Though I may not always agree with each of the articles highlighted, they will often provide an interesting argument for their position. We can take some concepts that may or may not align with our vision, then apply them to our framework, and voila, a new idea is born.
Saturday, September 30, 2017
Thursday, September 28, 2017
Abbott Laboratories (ABT) Dividend Stock Analysis
Linked here is a detailed quantitative analysis of Abbott Laboratories (ABT). Below are some highlights from the above linked analysis:
Company Description: This diversified health care products company is now focused on nutritionals, diagnostics, generic drugs, and medical devices, following the spinoff of its R&D-based prescription pharmaceuticals business at the beginning of 2013.
Company Description: This diversified health care products company is now focused on nutritionals, diagnostics, generic drugs, and medical devices, following the spinoff of its R&D-based prescription pharmaceuticals business at the beginning of 2013.
Labels:
Analysis
Wednesday, September 27, 2017
7 Stocks With Strong Dividend Growth Metrics
When evaluating a company as a potential income investment I look at its calculated fair value, ability to generate cash, debt position and the net present value of its dividend stream compared to alternative "safe" investments (NPV MMA Differential).
Labels:
Classics,
Commentary
Tuesday, September 26, 2017
Amgen, Inc. (AMGN) Dividend Stock Analysis
Linked here is a detailed quantitative analysis of Amgen, Inc. (AMGN). Below are some highlights from the above linked analysis:
Company Description: Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
Company Description: Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
Labels:
Analysis
Monday, September 25, 2017
7 Stocks With A Vision Of Higher Dividends
Some traditionalist would say your home is your greatest wealth building asset. I would argue it is not. Others would say your income is your greatest wealth building asset. Thought there is a lot of truth to the statement, it is still not your greatest wealth building asset. So, what is your greatest wealth building asset? Everyone is born with it. Few realize its importance until they lose most of it. The asset is so priceless it can’t be bought. Your most valuable wealth building asset is time.
With time, you can wait for blue-chip stocks to build a high yield-on-cost by growing their dividends. Below are several companies building shareholder wealth by increasing their cash dividends:
With time, you can wait for blue-chip stocks to build a high yield-on-cost by growing their dividends. Below are several companies building shareholder wealth by increasing their cash dividends:
Labels:
Increases
Saturday, September 23, 2017
Weekly Links: September 23, 2017
Each weekend I highlight any notable articles that I came across over the past week. Though I may not always agree with each of the articles highlighted, they will often provide an interesting argument for their position. We can take some concepts that may or may not align with our vision, then apply them to our framework, and voila, a new idea is born.
Labels:
Increases
Subscribe to:
Posts (Atom)




